Literature DB >> 16983571

Clinical impact of CCM mutation detection in familial cavernous angioma.

Oguzkan Sürücü1, Ulrich Sure, Sabine Gaetzner, Sonja Stahl, Ludwig Benes, Helmut Bertalanffy, Ute Felbor.   

Abstract

INTRODUCTION AND
BACKGROUND: A 3-year-old Bosnian girl with a large symptomatic brainstem and multiple supratentorial cavernous angiomas, who underwent neurosurgical treatment, is presented. As multiple cavernomas are more common in familial cases, genetic analyses and neuroradiological imaging were performed in the patient and her parents to see whether there was any evidence for inheritance. This information is important for genetic counseling and provision of medical care for at-risk relatives. Currently, no recommendation is available on how to manage these cases.
RESULTS: Genetic analyses demonstrated a novel CCM1 frameshift mutation (c.1683_1684insA; p.V562SfsX6) in the child and the asymptomatic 27-year-old mother. Sensitive gradient-echo magnetic resonance imaging of the mother revealed multiple supratentorial lesions, whereas analogous imaging of the father showed no pathological findings.
CONCLUSION: This case exemplifies that seemingly sporadic cases with multiple lesions might well be hereditary and that presymptomatic genetic testing of family members may identify relatives for whom clinical and neuroradiological monitoring is indicated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16983571     DOI: 10.1007/s00381-006-0202-8

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  16 in total

Review 1.  Cerebral cavernomas in the adult. Review of the literature and analysis of 72 surgically treated patients.

Authors:  Helmut Bertalanffy; Ludwig Benes; Takahito Miyazawa; Olaf Alberti; Adrian M Siegel; Ulrich Sure
Journal:  Neurosurg Rev       Date:  2002-03       Impact factor: 3.042

Review 2.  Intracranial cavernous angioma: a practical review of clinical and biological aspects.

Authors:  Ratul Raychaudhuri; H Huntington Batjer; Issam A Awad
Journal:  Surg Neurol       Date:  2005-04

3.  Low frequency of PDCD10 mutations in a panel of CCM3 probands: potential for a fourth CCM locus.

Authors:  Christina L Liquori; Michel J Berg; Ferdinando Squitieri; Monica Ottenbacher; Marielle Sorlie; Tracey P Leedom; Milena Cannella; Vittorio Maglione; Louis Ptacek; Eric W Johnson; Douglas A Marchuk
Journal:  Hum Mutat       Date:  2006-01       Impact factor: 4.878

4.  Germline mutations in the CCM1 gene, encoding Krit1, cause cerebral cavernous malformations.

Authors:  M Lucas; A F Costa; M Montori; F Solano; M D Zayas; G Izquierdo
Journal:  Ann Neurol       Date:  2001-04       Impact factor: 10.422

Review 5.  Cerebral cavernous malformations: mutations in Krit1.

Authors:  D J Verlaan; W J Davenport; H Stefan; U Sure; A M Siegel; G A Rouleau
Journal:  Neurology       Date:  2002-03-26       Impact factor: 9.910

6.  Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas.

Authors:  S Laberge-le Couteulx; H H Jung; P Labauge; J P Houtteville; C Lescoat; M Cecillon; E Marechal; A Joutel; J F Bach; E Tournier-Lasserve
Journal:  Nat Genet       Date:  1999-10       Impact factor: 38.330

7.  CCM3 mutations are uncommon in cerebral cavernous malformations.

Authors:  D J Verlaan; J Roussel; S B Laurent; C E Elger; A M Siegel; G A Rouleau
Journal:  Neurology       Date:  2005-12-27       Impact factor: 9.910

8.  CCM2 mutations account for 13% of cases in a large collection of kindreds with hereditary cavernous malformations.

Authors:  Dominique J Verlaan; Sandra B Laurent; Daniel L Rochefort; Christina L Liquori; Douglas A Marchuk; Adrian M Siegel; Guy A Rouleau
Journal:  Ann Neurol       Date:  2004-05       Impact factor: 10.422

9.  Mutations within the MGC4607 gene cause cerebral cavernous malformations.

Authors:  C Denier; S Goutagny; P Labauge; V Krivosic; M Arnoult; A Cousin; A L Benabid; J Comoy; P Frerebeau; B Gilbert; J P Houtteville; M Jan; F Lapierre; H Loiseau; P Menei; P Mercier; J J Moreau; A Nivelon-Chevallier; F Parker; A M Redondo; J M Scarabin; M Tremoulet; M Zerah; J Maciazek; E Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2004-01-22       Impact factor: 11.025

10.  Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations.

Authors:  Christina L Liquori; Michel J Berg; Adrian M Siegel; Elizabeth Huang; Jon S Zawistowski; T'Prien Stoffer; Dominique Verlaan; Fiyinfolu Balogun; Lori Hughes; Tracey P Leedom; Nicholas W Plummer; Milena Cannella; Vittorio Maglione; Ferdinando Squitieri; Eric W Johnson; Guy A Rouleau; Louis Ptacek; Douglas A Marchuk
Journal:  Am J Hum Genet       Date:  2003-11-17       Impact factor: 11.025

View more
  10 in total

1.  CCM1 gene deletion identified by MLPA in cerebral cavernous malformation.

Authors:  Sabine Gaetzner; Sonja Stahl; Oguzkan Sürücü; Anne Schaafhausen; Birgit Halliger-Keller; Helmut Bertalanffy; Ulrich Sure; Ute Felbor
Journal:  Neurosurg Rev       Date:  2006-12-23       Impact factor: 3.042

2.  Familial cerebral cavernous angiomas: clinical and genetic features in a Chinese family with a frame-shift mutation in the CCM1 gene (krit1).

Authors:  Hui Zhu; Yingjie Guo; Xuemin Feng; Rensheng Zhang; Chunkui Zhou; Guibo Li; Jingyao Liu
Journal:  J Mol Neurosci       Date:  2014-09-04       Impact factor: 3.444

3.  A retrospective and consecutive analysis of the epidemiology and management of spinal cavernomas over the last 20 years in a single center.

Authors:  Ardeshir Ardeshiri; Neriman Özkan; Bixia Chen; Klaus-Peter Stein; Dorothea Miller; Bernd-Otto Hütter; Ibrahim Erol Sandalcioglu; Ulrich Sure
Journal:  Neurosurg Rev       Date:  2015-12-02       Impact factor: 3.042

4.  Stabilization of VEGFR2 signaling by cerebral cavernous malformation 3 is critical for vascular development.

Authors:  Yun He; Haifeng Zhang; Luyang Yu; Murat Gunel; Titus J Boggon; Hong Chen; Wang Min
Journal:  Sci Signal       Date:  2010-04-06       Impact factor: 8.192

5.  A Novel KRIT1/CCM1 Gene Insertion Mutation Associated with Cerebral Cavernous Malformations in a Chinese Family.

Authors:  Hui Wang; Yunzhu Pan; Zaiqiang Zhang; Xingang Li; Zhe Xu; Yue Suo; Wei Li; Yongjun Wang
Journal:  J Mol Neurosci       Date:  2017-02-03       Impact factor: 3.444

6.  CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations.

Authors:  Katrin Voss; Sonja Stahl; Elisa Schleider; Sybille Ullrich; Joachim Nickel; Thomas D Mueller; Ute Felbor
Journal:  Neurogenetics       Date:  2007-07-27       Impact factor: 2.660

7.  Predictive genetic testing of at-risk relatives requires analysis of all CCM genes after identification of an unclassified CCM1 variant in an individual affected with cerebral cavernous malformations.

Authors:  Winnie Schröder; Juliane Najm; Stefanie Spiegler; Martina Mair; Julio Viera; Wolfram Henn; Ute Felbor
Journal:  Neurosurg Rev       Date:  2013-05-31       Impact factor: 3.042

8.  A founder mutation in the Ashkenazi Jewish population affecting messenger RNA splicing of the CCM2 gene causes cerebral cavernous malformations.

Authors:  Carol J Gallione; Ann Solatycki; Issam A Awad; James L Weber; Douglas A Marchuk
Journal:  Genet Med       Date:  2011-07       Impact factor: 8.822

9.  High mutation detection rates in cerebral cavernous malformation upon stringent inclusion criteria: one-third of probands are minors.

Authors:  Stefanie Spiegler; Juliane Najm; Jian Liu; Stephanie Gkalympoudis; Winnie Schröder; Guntram Borck; Knut Brockmann; Miriam Elbracht; Christine Fauth; Andreas Ferbert; Leonie Freudenberg; Ute Grasshoff; Yorck Hellenbroich; Wolfram Henn; Sabine Hoffjan; Irina Hüning; G Christoph Korenke; Peter M Kroisel; Erdmute Kunstmann; Martina Mair; Susanne Munk-Schulenburg; Omid Nikoubashman; Silke Pauli; Sabine Rudnik-Schöneborn; Irene Sudholt; Ulrich Sure; Sigrid Tinschert; Michaela Wiednig; Barbara Zoll; Mark H Ginsberg; Ute Felbor
Journal:  Mol Genet Genomic Med       Date:  2014-01-14       Impact factor: 2.183

10.  A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.

Authors:  Axel Pagenstecher; Sonja Stahl; Ulrich Sure; Ute Felbor
Journal:  Hum Mol Genet       Date:  2008-12-16       Impact factor: 6.150

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.